Alzmenda 10 Mg 14 Tablets

Alzmenda 10 Mg 14 Tablets

Description:

Alzmenda 10 mg 14 tablets is a prescription oral medicine containing memantine, an antidementia agent used in the management of moderate to severe Alzheimer’s disease. Memantine is an N-methyl-D-aspartate (NMDA) receptor antagonist that helps regulate abnormal glutamate activity in the brain, which is associated with neuronal damage and cognitive decline. Alzmenda is designed for adult patients and is typically used as part of a comprehensive treatment plan under the supervision of a neurologist or psychiatrist.

Indications:

• Treatment of moderate to severe Alzheimer’s disease in adults.
• Helps manage symptoms such as memory loss, confusion, disorientation, and difficulties with thinking, learning, and daily activities.
• Supports stabilization or slowing of cognitive and functional decline associated with Alzheimer’s disease.

Active Ingredients / Key Components:

• Memantine hydrochloride – 10 mg per tablet (equivalent to 10 mg memantine).
• Excipients: Information on inactive ingredients (such as fillers, binders, coating agents, colorants, and preservatives) is not available in the provided data. Please refer to the official package leaflet for the full excipient list.

Dosage & Administration / How to Use:

• Alzmenda 10 mg tablets are for oral use only and should be taken exactly as prescribed by the treating physician.
• Typical dosing with memantine involves gradual dose titration; the exact starting dose, titration schedule, and maintenance dose must be determined by the doctor based on the patient’s condition and tolerance.
• Tablets are usually taken once daily, at the same time each day. They may be taken with or without food, with a glass of water.
• Do not crush or chew the tablets unless your doctor or pharmacist specifically instructs otherwise.
• If a dose is missed, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed dose.
• Do not stop taking Alzmenda suddenly without consulting your doctor, as treatment interruption should be medically supervised.
• Elderly patients and those with kidney impairment may require dose adjustment; this must be assessed and prescribed by the physician.

Clinical Benefits:

• Helps slow the progression of cognitive decline in moderate to severe Alzheimer’s disease.
• Supports improvement or stabilization of memory, attention, and thinking functions in some patients.
• May help maintain the ability to perform daily activities (such as personal care and basic household tasks) for a longer period.
• Reduces excessive glutamate-mediated neuronal damage by blocking overactivation of NMDA receptors, contributing to neuroprotection.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to memantine or any of the excipients in the formulation.
• Use with caution in patients with a history of seizures, uncontrolled epilepsy, or conditions that may increase seizure risk.
• Use with caution and possible dose adjustment in patients with renal impairment (kidney disease); severe renal impairment requires strict medical supervision.
• Use with caution in patients with recent myocardial infarction, uncompensated congestive heart failure, or uncontrolled hypertension.
• Memantine may interact with other medications that affect NMDA receptors or alter urinary pH (e.g., certain carbonic anhydrase inhibitors, sodium bicarbonate); inform your doctor about all medicines and supplements you are taking.
• May cause dizziness, drowsiness, or confusion; patients should avoid driving, operating machinery, or performing tasks requiring alertness until they know how the medicine affects them.
• Consult your doctor before use if pregnant, nursing, taking medications, or have medical conditions such as kidney disease, liver disease, seizure disorders, heart disease, or uncontrolled hypertension.
• Not recommended for use in children and adolescents, as safety and efficacy in this age group have not been established.
• Keep out of reach of children.
• This product is a prescription medicine and must be used only under medical supervision.

Side Effects:

• Common side effects may include dizziness, headache, confusion, drowsiness, constipation, and elevated blood pressure.
• Other possible side effects can include fatigue, balance problems, shortness of breath, increased liver enzymes, and hallucinations in some patients.
• Serious side effects (seek immediate medical attention) may include severe allergic reactions (rash, itching, swelling of face or throat, difficulty breathing), seizures, severe confusion, or marked changes in behavior or mood.
• Not all patients will experience side effects. If any side effect is persistent, severe, or concerning, contact your doctor or pharmacist promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date stated on the package. Do not store above the temperature specified in the official leaflet (temperature information is not available in the provided data; refer to the pack for exact storage temperature).

Specifications:

• Product type: Prescription medicine for Alzheimer’s disease.
• Active ingredient: memantine hydrochloride 10 mg per tablet.
• Form: Film-coated tablet.
• Pack size: 14 tablets per pack.
• Intended use: Adult patients with moderate to severe Alzheimer’s disease, under medical supervision.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.